NDC11 73362010002
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73362-0100-02 | 73362-0100 |
| 73362-0100-2 | 73362-0100 |
| 73362-100-02 | 73362-100 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Yorvipath | PALOPEGTERIPARATIDE | Ascendis Pharma, Endocrinology, Inc. | a1fa23fd-c434-443e-9a17-5750578c8602 | 2026-08-12 | Warnings, Adverse reactions | 73362-100-02 73362-100 73362010002 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.